04/23/2024
3:11 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:21 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
2:07 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
8:49 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
8:54 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2024
3:24 PM | BioMarin Pharmaceutical (Filer)
| Form ARS | |
04/09/2024
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A | |
|
04/09/2024
3:09 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A | |
03/20/2024
4:13 PM | BioMarin Pharmaceutical (Issuer)
Slamon Dennis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:48 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:50 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:53 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:55 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:36 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:40 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:42 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:46 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:54 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:32 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:35 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
11:04 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
1:41 PM | BioMarin Pharmaceutical (Subject)
FUCHS HENRY J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
11:04 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:10 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:12 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:14 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:16 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:18 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:05 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
9:35 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
12:34 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2024
12:21 PM | BioMarin Pharmaceutical (Subject)
DODGE & COX (Filed by)
| Form SC 13G/A | |
02/12/2024
4:20 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
2:24 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/09/2024
4:46 PM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SC 13G | |
02/09/2024
9:36 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024
8:46 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
6:47 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:06 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
1:40 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
9:09 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Thousands of investors use this no cost solution | Do you? (Ad) In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve.
Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" |
01/09/2024
10:48 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023
12:00 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:03 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
12:11 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:13 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
12:15 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:18 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:14 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
8:57 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
4:22 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
5:18 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
10:49 AM | BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
6:55 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:13 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
1:53 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/17/2023
2:57 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
9:27 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023
12:59 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
12:35 PM | BioMarin Pharmaceutical (Subject)
FUCHS HENRY J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023
6:05 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
6:08 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
12:30 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2023
9:39 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
11:48 AM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023
3:05 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
10:35 AM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:23 PM | Alles Mark J (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:24 PM | ANDERSON ELIZABETH M (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:24 PM | BioMarin Pharmaceutical (Issuer)
Dere Willard H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:25 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:26 PM | BioMarin Pharmaceutical (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:26 PM | BioMarin Pharmaceutical (Issuer)
HOMBACH ROBERT J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:27 PM | BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:27 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:28 PM | BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:29 PM | BioMarin Pharmaceutical (Issuer)
Slamon Dennis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
4:31 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
4:19 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
5:14 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
5:14 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
4:22 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
11:44 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023
8:48 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023
10:23 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/28/2023
12:23 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
